Innate Pharma S.A.

IPHANASDAQHealthcare● Active

$1.76

+$0.05(+2.92%)

Market Cap$165269787

P/E Ratio—

52W High$2.63

52W Low$1.17

Avg Volume68K

Open$1.73

Beta0.89

Overview

Innate Pharma S.A. (IPHA) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · IPHA · as of Apr 1, 2026

Latest filing snapshot

125

-56-30.94%vs prior year

Innate Pharma S.A. (IPHA) employee data is sourced from the annual SEC 20-F filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 20-F·Period end: 2025-12-31·Full-time · Global

Total Employees

125

Change (1Y)

-56

Growth % (1Y)

-30.94%

Revenue / Employee

$22.3K

Net Income / Employee

$-393.4K

Market Cap

$165M

IPHA Employee Count

2019 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2026-04-01	2025-12-31	125	-56	-30.94%
2025-04-30	2024-12-31	181	+2	+1.12%
2024-04-04	2023-12-31	179	-32	-15.17%
2023-04-06	2022-12-31	211	-3	-1.40%
2022-04-04	2021-12-31	214	-31	-12.65%
2021-04-27	2020-12-31	245	+10	+4.26%
2020-04-24	2019-12-31	235	—	—

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

IPHA

Innate Pharma S.A.YOU

Applied Therapeutics, Inc.

35$15M #5

CRDF

Cardiff Oncology, Inc.

32$103M #6

ELTX

Elicio Therapeutics, Inc.

32$259M #7

CRBP

Corbus Pharmaceuticals Holdings, Inc.

28$95M

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · IPHA peer comparison

About IPHA employees

IPHA Employees · Headcount

Innate Pharma S.A. (IPHA) employee data is sourced from the annual SEC 20-F filing. As of 2025, Innate Pharma S.A. had 125 full-time employees globally. Full-time employees only. Global consolidated headcount.

Innate Pharma S.A. employs 125 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $22,296, reflecting the company's operational efficiency.

Innate Pharma S.A.'s workforce decreased by 56 (30.94%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Innate Pharma S.A.'s revenue per employee of $22,296 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

IPHA Employees · 5 questions

As of the latest SEC 20-F filing (2025), Innate Pharma S.A. had 125 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Innate Pharma S.A. employee counthow many employees does Innate Pharma S.A. haveIPHA total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-04-01